Expert NetworkExpert InterviewBIIB

Slingshot members are talking to an expert! The topic is:

Discussing the potential of high-dose Spinraza (nusinersen) from Biogen for SMA patients in the DEVOTE and ASCEND studies

Executed on:Nov 5, 2025 9:30 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Johns Hopkins University
  • Codirector of the Muscular Dystrophy Association Clinic and Professor of Neurology at Johns Hopkins
  • Manages 30+ patients with SMA
  • Primary research interests involve the basic science and clinical characterization of two important neurologic disorders that affect children: Spinal Muscular Atrophy and Ataxia Telangiectasia. SI on various SMA agents, both investigational and approved

Interview Goal

Discuss current landscape of therapies of SMA and the potential of high-dose Spinraza

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.